Researchers
Discover all researchers in life sciences
Loading researchers...
İmren Bayıl
Researcher at Research Department
Bioactive Compounds And Antitumor Agents
Crystallization And Solubility Studies
Drug Discovery
Research On Leishmaniasis Studies
Synthesis And Biological Activity
290
Citations
9
H-index
0
Patents
28
Publications
0
Grants
$0
Total Funding
AI Research AssistantBeta
Ask questions about İmren Bayıl's research, publications, and ongoing work
What are their main research contributions?
Show me their collaboration network
What grants fund their research?
Research Contributions
Computational Design of Apigenin Derivatives for Cervical Cancer Inhibition
Developed novel computational and drug design strategies for inhibiting human papillomavirus-associated cervical cancer using Apigenin derivatives, published in Scientific Reports.
Scientific Reports (2023)
Computational Approach for Antimalarial Drug Discovery
Employed advanced computational methods to discover antimalarial drugs by modifying haplopine, published in Journal of Cellular and Molecular Medicine.
Journal of Cellular and Molecular Medicine (2023)
In Silico Design of VEGFR-2 Target Inhibitors
Designed and analyzed benzoxazole and benzothiazole derivatives as VEGFR-2 target inhibitors using in silico methods, published in Intelligent Pharmacy.
Intelligent Pharmacy (2023)
Drug Design Strategy for Triple-Negative Breast Cancer
Applied molecular docking and dynamics simulations to develop inhibitors against triple-negative breast cancer using Scutellarein derivatives, published in PLoS ONE.
PLoS ONE (2023)
Computational Analysis of Phytocompounds Against Helicobacter pylori
Investigated the mechanistic inhibition of Helicobacter pylori by selected phytocompounds using a computational approach, published in Heliyon.
Heliyon (2023)
In Silico Strategy for West Nile Virus Inhibition
Utilized molecular docking and dynamics simulations to identify inhibitors for West Nile virus envelope glycoprotein and methyltransferase, published in Frontiers in Microbiology.
Frontiers in Microbiology (2023)
Computational Drug Design for Anti-parasitic Agents Against Babesia microti
Employed a computational drug design approach to discover anti-parasitic drugs against Babesia microti using natural compounds, published in Frontiers in Cellular and Infection Microbiology.
Frontiers in Cellular and Infection Microbiology (2023)
Research Highlights
Dr. Bayıl is a leading researcher in computational drug design, utilizing advanced techniques to identify and develop novel therapeutics for cancer, parasitic diseases, and viral infections. His work focuses on in silico methods, including molecular docking and dynamics simulations, to accelerate drug discovery.
Research Areas
Bioactive Compounds And Antitumor AgentsCrystallization And Solubility StudiesDrug DiscoveryResearch On Leishmaniasis StudiesSynthesis And Biological Activity
Similar Researchers You Should Know
Researchers with overlapping expertise and complementary work
Finding similar researchers...